Statement of Organization, Functions and Delegations of Authority, 52734-52735 [2014-21010]

Download as PDF 52734 Federal Register / Vol. 79, No. 171 / Thursday, September 4, 2014 / Notices Intended Recipient of the Award: The University of Washington, NWAETC (Grant # H4AHA00051). The amount of the noncompetitive award is $250,239. SUPPLEMENTARY INFORMATION: Dated: August 27, 2014. Mary K. Wakefield, Administrator. Section RR–20, Functions [FR Doc. 2014–21012 Filed 9–3–14; 8:45 am] BILLING CODE 4165–15–P Authority: Section 2692 of the Public Health Service Act, 42, U.S.C. 300ff–111. mstockstill on DSK4VPTVN1PROD with NOTICES CFDA Number: 93.145 Period of Supplemental Funding: July 1, 2014, through June 30, 2015. Justification: With the implementation of the Affordable Care Act, more people, including those living with HIV/AIDS, are able to access care and are being seen by providers in a variety of settings, including community health care centers. This has resulted in an increased need for primary care providers to receive training in HIV care. A program expansion supplement will allow the NWAETC to develop a comprehensive portfolio of web-based, HIV primary care distance learning and assessment resources and tools that will reach greater numbers of health care providers across the nation. This free, state-of-the-art HIV care and treatment curriculum will be evidence-based and aligned with up-to-date federal guidelines. Further, the curriculum would be accessed in an online environment that is effective at assessing HIV training needs, providing relevant, tailored training to meet those needs, and will monitor and evaluate individual and group progress throughout the curriculum. The University of Washington NWAETC, now in the fifth year of a 5-year project ending on June 30, 2015, is uniquely positioned to rapidly develop and deliver the national HIV care and treatment distance curriculum, having the necessary infrastructure for implementation already developed and in place, and having previously demonstrated the capacity to develop similar products. A distance HIV curriculum is consistent with the goals of the AETC program—to provide HIV treatment education, clinical consultation, capacity building, and technical assistance to health care professionals and agencies. An on-line HIV care and treatment training curriculum will help to better meet the HIV training needs of the current health care workforce that is working to achieve the goals of the National HIV/ AIDS Strategy (NHAS). FOR FURTHER INFORMATION CONTACT: Rupali K. Doshi, MD, MS, Acting Branch Chief, HIV Education Branch, Division of Training and Capacity Development, HAB/HRSA, 5600 Fishers Lane, Rockville, Maryland 20857, by email at rdoshi@hrsa.gov, or by phone at (301) 443–5313. VerDate Mar<15>2010 18:14 Sep 03, 2014 Jkt 232001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization, Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at Vol. 79, FR 31952– 31956 dated June 3, 2014). This notice reflects organizational changes to the Health Resources and Services Administration. This notice updates the functional statement for the Healthcare Systems Bureau (RR). Specifically this notice: (1) Renames the Division of Vaccine Injury Compensation to the Division of Injury Compensation Programs (RR4); (2) transfers the Countermeasures Injury Compensation Program function from the Office of the Associate Administrator (RR) to the newly named Division of Injury Compensation Programs (RR4); (3) updates the functional statement for the Office of the Associate Administrator (RR); and (4) updates the functional statement for the Division of Injury Compensation Programs (RR4). Chapter RR—Healthcare Systems Bureau Section RR–10, Organization Delete the organization for the Healthcare Systems Bureau (RR) in its entirety and replace with the following: The Healthcare Systems Bureau (RR) is headed by the Associate Administrator, who reports directly to the Administrator, Health Resources Services Administration. (1) Office of the Associate Administrator (RR); (2) Division of Transplantation (RR1); (3) Division of Injury Compensation Programs (RR4); (4) Office of Pharmacy Affairs (RR7); (5) Division of Poison Control and Healthcare Facilities (RR9); and (6) Division of National Hansen’s Disease Program (RRH). PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 Delete the functional statement for the Office of the Associate Administrator (RR), and the functional statement for the Division of Vaccine Injury Compensation (RR4), and replace in its entirety. Office of the Associate Administrator (RR) The Healthcare Systems Bureau leads the agency in providing health care programs to eligible organizations around the country. Specifically, (1) administers the Organ Transplantation Program to include the Organ Procurement and Transplantation Network (OPTN) to facilitate the allocation of donor organs to patients waiting for an organ transplant, and the Scientific Registry of Transplant Recipients that provides analytic support to the OPTN in the development and assessment of organ allocation and other OPTN policies; (2) administers the C.W. Bill Young Cell Transplantation Program to increase the number of unrelated blood stem cell transplants and improve the outcomes of blood stem cell transplants; (3) administers the National Cord Blood Inventory to increase the number of high quality cord blood units available for transplantation; (4) develops and maintains a national program of grants and contracts to organ procurement organizations and other entities to increase the number of organs made available for transplantation; (5) manages the national program for compliance with the Hill-Burton uncompensated care requirement and other assurances; (6) directs and administers a congressionally-directed grant program for the construction/ renovation/equipping of health care and other facilities; (7) directs and administers the National Vaccine Injury Compensation Program; (8) manages and promotes the 340B Drug Pricing Program; (9) directs and administers the Poison Center Support, Enhancement, and Awareness Act; (10) implements and administers the Countermeasures Injury Compensation Program; (11) provides professional and administrative support for the HHS Medical Review Claims Panel; and (12) manages the National Hansen’s Disease Program in accordance with regulations of the Public Health Service. Division of Injury Compensation Programs (RR4) The Division of Injury Compensation Programs, on behalf of the Secretary of Health and Human Services (HHS), administers and implements all E:\FR\FM\04SEN1.SGM 04SEN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 79, No. 171 / Thursday, September 4, 2014 / Notices statutory and charter authorities related to the operations of the National Vaccine Injury Compensation Program, the Countermeasures Injury Compensation Program, and the Department of Health and Human Services Medical Review Claims Panel by: (1) Evaluating claims for compensation filed under the National Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program through medical review and assessment of compensability for all complete claims; (2) processing awards for compensation made under the National Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program; (3) promulgating regulations to develop and revise Vaccine and Countermeasures Injury Tables; (4) providing professional and administrative support to the Advisory Commission on Childhood Vaccines (ACCV) and the Medical Claims Review Panel; (5) maintaining responsibility for activities related to the ACCV including the development of policy, regulations, budget formulation, and legislation; the development and renewal of its charter and action memoranda to the Secretary; and the analysis of its findings and proposals; (6) developing and maintaining all automated information systems necessary for program implementation; (7) developing and disseminating program information; (8) maintaining a working relationship with the Department of Justice (DOJ) and the U.S. Court of Federal Claims through the DOJ, in the administration and operation of the National Vaccine Injury Compensation Program; (9) providing management, direction, budgetary oversight, coordination, and logistical support for the Medical Expert Panel, as well as Clinical Reviewer contracts; (10) developing, reviewing, and analyzing pending and new legislation relating to program changes, new initiatives, the ACCV, and changes to the Vaccine and Countermeasures Injury Tables, in coordination with the Office of the General Counsel; (11) providing programmatic outreach efforts to maximize public exposure to private and public constituencies; (12) providing submission of special reports to the Secretary of HHS, the Office of Management and Budget, Congress, and other governmental bodies; and (13) providing guidance in using the results and decisions of the Medical Claims Review Panel to HHS Operating Divisions to improve the quality of health care in its facilities and by its practitioners. VerDate Mar<15>2010 18:14 Sep 03, 2014 Jkt 232001 Section RR–30, Delegations of Authority All delegations of authority and redelegations of authority made to HRSA officials that were in effect immediately prior to this reorganization, and that are consistent with this reorganization, shall continue in effect pending further re-delegation. This reorganization is effective upon date of signature. Dated: August 25, 2014. Mary K. Wakefield, Administrator. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Neurological Disorders and Stroke, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke. Date: October 5–7, 2014. Time: 6:00 p.m. to 12:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Alan P. Koretsky, Ph.D., Scientific Director, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, NIH, 35 Convent Drive, Room GF144, Bethesda, MD 20892, (301) 435–2232, koretskya@ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). Frm 00111 Fmt 4703 Sfmt 4703 Dated: August 28, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–20933 Filed 9–3–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2014–21010 Filed 9–3–14; 8:45 am] PO 00000 52735 National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Initial Review Group Mental Health Services Research Committee. Date: October 2, 2014. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, Washington, DC 20037. Contact Person: Aileen Schulte, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6136, MSC 9606, Bethesda, MD 20852, 301–443–1225, aschulte@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group Interventions Committee for Disorders Involving Children and Their Families. Date: October 14, 2014. Time: 11:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6143, MSC 9606, Bethesda, MD 20892–9606, 301–443–9699, bursteinme@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group Interventions Committee for Adult Disorders. Date: October 14, 2014. Time: 1:30 p.m. to 5:00 p.m. E:\FR\FM\04SEN1.SGM 04SEN1

Agencies

[Federal Register Volume 79, Number 171 (Thursday, September 4, 2014)]
[Notices]
[Pages 52734-52735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21010]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Statement of Organization, Functions and Delegations of Authority

    This notice amends Part R of the Statement of Organization, 
Functions and Delegations of Authority of the Department of Health and 
Human Services (HHS), Health Resources and Services Administration 
(HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 
Vol. 79, FR 31952-31956 dated June 3, 2014).
    This notice reflects organizational changes to the Health Resources 
and Services Administration. This notice updates the functional 
statement for the Healthcare Systems Bureau (RR). Specifically this 
notice: (1) Renames the Division of Vaccine Injury Compensation to the 
Division of Injury Compensation Programs (RR4); (2) transfers the 
Countermeasures Injury Compensation Program function from the Office of 
the Associate Administrator (RR) to the newly named Division of Injury 
Compensation Programs (RR4); (3) updates the functional statement for 
the Office of the Associate Administrator (RR); and (4) updates the 
functional statement for the Division of Injury Compensation Programs 
(RR4).

Chapter RR--Healthcare Systems Bureau

Section RR-10, Organization

    Delete the organization for the Healthcare Systems Bureau (RR) in 
its entirety and replace with the following: The Healthcare Systems 
Bureau (RR) is headed by the Associate Administrator, who reports 
directly to the Administrator, Health Resources Services 
Administration.
    (1) Office of the Associate Administrator (RR);
    (2) Division of Transplantation (RR1);
    (3) Division of Injury Compensation Programs (RR4);
    (4) Office of Pharmacy Affairs (RR7);
    (5) Division of Poison Control and Healthcare Facilities (RR9); and
    (6) Division of National Hansen's Disease Program (RRH).

Section RR-20, Functions

    Delete the functional statement for the Office of the Associate 
Administrator (RR), and the functional statement for the Division of 
Vaccine Injury Compensation (RR4), and replace in its entirety.

Office of the Associate Administrator (RR)

    The Healthcare Systems Bureau leads the agency in providing health 
care programs to eligible organizations around the country. 
Specifically, (1) administers the Organ Transplantation Program to 
include the Organ Procurement and Transplantation Network (OPTN) to 
facilitate the allocation of donor organs to patients waiting for an 
organ transplant, and the Scientific Registry of Transplant Recipients 
that provides analytic support to the OPTN in the development and 
assessment of organ allocation and other OPTN policies; (2) administers 
the C.W. Bill Young Cell Transplantation Program to increase the number 
of unrelated blood stem cell transplants and improve the outcomes of 
blood stem cell transplants; (3) administers the National Cord Blood 
Inventory to increase the number of high quality cord blood units 
available for transplantation; (4) develops and maintains a national 
program of grants and contracts to organ procurement organizations and 
other entities to increase the number of organs made available for 
transplantation; (5) manages the national program for compliance with 
the Hill-Burton uncompensated care requirement and other assurances; 
(6) directs and administers a congressionally-directed grant program 
for the construction/renovation/equipping of health care and other 
facilities; (7) directs and administers the National Vaccine Injury 
Compensation Program; (8) manages and promotes the 340B Drug Pricing 
Program; (9) directs and administers the Poison Center Support, 
Enhancement, and Awareness Act; (10) implements and administers the 
Countermeasures Injury Compensation Program; (11) provides professional 
and administrative support for the HHS Medical Review Claims Panel; and 
(12) manages the National Hansen's Disease Program in accordance with 
regulations of the Public Health Service.

Division of Injury Compensation Programs (RR4)

    The Division of Injury Compensation Programs, on behalf of the 
Secretary of Health and Human Services (HHS), administers and 
implements all

[[Page 52735]]

statutory and charter authorities related to the operations of the 
National Vaccine Injury Compensation Program, the Countermeasures 
Injury Compensation Program, and the Department of Health and Human 
Services Medical Review Claims Panel by: (1) Evaluating claims for 
compensation filed under the National Vaccine Injury Compensation 
Program and the Countermeasures Injury Compensation Program through 
medical review and assessment of compensability for all complete 
claims; (2) processing awards for compensation made under the National 
Vaccine Injury Compensation Program and the Countermeasures Injury 
Compensation Program; (3) promulgating regulations to develop and 
revise Vaccine and Countermeasures Injury Tables; (4) providing 
professional and administrative support to the Advisory Commission on 
Childhood Vaccines (ACCV) and the Medical Claims Review Panel; (5) 
maintaining responsibility for activities related to the ACCV including 
the development of policy, regulations, budget formulation, and 
legislation; the development and renewal of its charter and action 
memoranda to the Secretary; and the analysis of its findings and 
proposals; (6) developing and maintaining all automated information 
systems necessary for program implementation; (7) developing and 
disseminating program information; (8) maintaining a working 
relationship with the Department of Justice (DOJ) and the U.S. Court of 
Federal Claims through the DOJ, in the administration and operation of 
the National Vaccine Injury Compensation Program; (9) providing 
management, direction, budgetary oversight, coordination, and 
logistical support for the Medical Expert Panel, as well as Clinical 
Reviewer contracts; (10) developing, reviewing, and analyzing pending 
and new legislation relating to program changes, new initiatives, the 
ACCV, and changes to the Vaccine and Countermeasures Injury Tables, in 
coordination with the Office of the General Counsel; (11) providing 
programmatic outreach efforts to maximize public exposure to private 
and public constituencies; (12) providing submission of special reports 
to the Secretary of HHS, the Office of Management and Budget, Congress, 
and other governmental bodies; and (13) providing guidance in using the 
results and decisions of the Medical Claims Review Panel to HHS 
Operating Divisions to improve the quality of health care in its 
facilities and by its practitioners.

Section RR-30, Delegations of Authority

    All delegations of authority and re-delegations of authority made 
to HRSA officials that were in effect immediately prior to this 
reorganization, and that are consistent with this reorganization, shall 
continue in effect pending further re-delegation.
    This reorganization is effective upon date of signature.

    Dated: August 25, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014-21010 Filed 9-3-14; 8:45 am]
BILLING CODE 4165-15-P